According to data from the World Health Organization, approximately 225,000 new ovarian cancer cases are reported globally each year, with HGSOC accounting for the vast majority, and its mortality rate ranking among the highest of all gynecological malignancies ( HGSOC is typically diagnosed at an advanced stage, a phenomenon that results in an extremely poor prognosis, as the absence of early diagnosis and effective treatment contributes to a continuous increase in mortality rates ( The clinical manifestations of HGSOC are typically not apparent in the early stages, with patients potentially experiencing non-specific symptoms such as abdominal distension, abdominal pain, decreased appetite, and weight changes, which render early diagnosis particularly challenging
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Without enough B12, nerves can get damaged
While most research has focused on gut and tendon healing, its anti-inflammatory mechanisms are relevant to skin conditions
